Cite
MLA Citation
David Z. I. Cherney et al.. “Kidney outcomes using a sustained ≥40% decline in eGFR: A meta‐analysis of SGLT2 inhibitor trials.” Clinical cardiology, vol. 44, no. 8, 2021, pp. 1139–1143. http://access.bl.uk/ark:/81055/vdc_100140198723.0x00004e